Paulson & CO. Inc. raised its stake in Monsanto Company (NYSE:MON) by 348.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 159,200 shares of the basic materials company’s stock after acquiring an additional 123,700 shares during the quarter. Paulson & CO. Inc.’s holdings in Monsanto were worth $18,843,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in MON. Iridian Asset Management LLC CT bought a new position in Monsanto in the 1st quarter valued at about $1,444,000. Tiedemann Wealth Management LLC bought a new position in Monsanto in the 1st quarter valued at about $234,000. Clifford Swan Investment Counsel LLC raised its holdings in Monsanto by 1.0% in the 1st quarter. Clifford Swan Investment Counsel LLC now owns 166,410 shares of the basic materials company’s stock valued at $18,838,000 after acquiring an additional 1,685 shares during the period. Baird Financial Group Inc. raised its holdings in Monsanto by 20.1% in the 1st quarter. Baird Financial Group Inc. now owns 19,254 shares of the basic materials company’s stock valued at $2,180,000 after acquiring an additional 3,219 shares during the period. Finally, Penserra Capital Management LLC raised its holdings in Monsanto by 9.5% in the 1st quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock valued at $145,000 after acquiring an additional 112 shares during the period. 74.77% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Monsanto Company (NYSE:MON) traded down 0.241% during mid-day trading on Tuesday, reaching $122.125. 1,111,818 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $118.79 and a 200 day moving average price of $117.33. The firm has a market cap of $53.67 billion, a P/E ratio of 23.998 and a beta of 1.07. Monsanto Company has a 52-week low of $97.35 and a 52-week high of $122.80.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.61. The firm had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The business’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.07 EPS. Analysts forecast that Monsanto Company will post $5.70 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s payout ratio is 42.27%.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Week Herald and is the property of of Week Herald. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://weekherald.com/2017/10/17/monsanto-company-mon-shares-bought-by-paulson-co-inc.html.
Several research analysts have weighed in on MON shares. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 5th. BMO Capital Markets reissued a “buy” rating and issued a $128.00 price target on shares of Monsanto in a report on Friday, September 1st. BidaskClub raised shares of Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $128.00 price target (up from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Finally, Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a report on Wednesday, July 12th. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $124.61.
In other news, EVP Steven Mizell sold 11,526 shares of the stock in a transaction on Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Brett D. Begemann sold 22,640 shares of the stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the transaction, the chief operating officer now directly owns 85,439 shares in the company, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. Insiders sold a total of 37,026 shares of company stock worth $4,440,341 in the last three months. Insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.